Acute Kidney Injury

A partnership will put penKid assays in more labs for timely and precise kidney health assessment in critical care settings.

Researchers studied predictors of acute kidney injury (AKI) and mortality in a population of US veterans with COVID-19.

The JuxtaFlow RAD has shown potential to protect patients from AKI after cardiac surgery with cardiopulmonary bypass.

Patients who experienced an acute kidney injury had a greater risk of being diagnosed with dementia after the AKI incident.

Little research has focused on risk factors for and clinical outcomes of AKI in patients with SFTS.

Could IV amino acid therapy result in a lower occurrence of postoperative acute kidney injury (AKI) after cardiac surgery?

A simple risk score could help predict a patient’s susceptibility to cisplatin-associated acute kidney injury (CP-AKI).

Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients?

The FDA granted a patent to Unicycive Therapeutics for UNI-494, a drug to treat acute kidney injury (AKI).

Patients with COVID-19–associated AKI seem to have better outcomes than those with AKI related to other respiratory ...

What is the specific impact of acute kidney injury (AKI) on in-hospital mortality among octogenarian patients with COVID-19?

The FDA gave Breakthrough Device designation to the JuxtaFlow RAD to help prevent AKI during cardiothoracic surgery.

Knowledge Hubs